JP6895424B2 - Ｂａｃｅ１阻害剤 - Google Patents
Ｂａｃｅ１阻害剤 Download PDFInfo
- Publication number
- JP6895424B2 JP6895424B2 JP2018506862A JP2018506862A JP6895424B2 JP 6895424 B2 JP6895424 B2 JP 6895424B2 JP 2018506862 A JP2018506862 A JP 2018506862A JP 2018506862 A JP2018506862 A JP 2018506862A JP 6895424 B2 JP6895424 B2 JP 6895424B2
- Authority
- JP
- Japan
- Prior art keywords
- fluorophenyl
- trimethyl
- tetrahydro
- isothiazolo
- oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940125759 BACE1 protease inhibitor Drugs 0.000 title description 2
- -1 ii) Independently Chemical group 0.000 claims description 335
- 150000001875 compounds Chemical class 0.000 claims description 191
- 150000001408 amides Chemical class 0.000 claims description 41
- 229910052736 halogen Inorganic materials 0.000 claims description 39
- 150000002367 halogens Chemical class 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 38
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 125000001424 substituent group Chemical group 0.000 claims description 27
- 208000024827 Alzheimer disease Diseases 0.000 claims description 26
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 25
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 25
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 22
- 102100021257 Beta-secretase 1 Human genes 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 14
- 208000037259 Amyloid Plaque Diseases 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 125000001072 heteroaryl group Chemical group 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 238000011321 prophylaxis Methods 0.000 claims description 9
- 230000001225 therapeutic effect Effects 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 208000037765 diseases and disorders Diseases 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 4
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims description 2
- BWBHNKMXZHIPGB-UHFFFAOYSA-N 4-cyano-3-methylpyridine-2-carboxamide Chemical compound CC1=C(C#N)C=CN=C1C(N)=O BWBHNKMXZHIPGB-UHFFFAOYSA-N 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 519
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 321
- 230000002829 reductive effect Effects 0.000 description 226
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 174
- 239000000203 mixture Substances 0.000 description 159
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 144
- 239000000243 solution Substances 0.000 description 122
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 108
- 238000000034 method Methods 0.000 description 106
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 99
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 85
- 239000012043 crude product Substances 0.000 description 85
- 238000004128 high performance liquid chromatography Methods 0.000 description 81
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 77
- 239000000741 silica gel Substances 0.000 description 71
- 229910002027 silica gel Inorganic materials 0.000 description 71
- 238000004440 column chromatography Methods 0.000 description 69
- 230000014759 maintenance of location Effects 0.000 description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 66
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 63
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 62
- 239000000543 intermediate Substances 0.000 description 62
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 59
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 54
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 48
- 239000011541 reaction mixture Substances 0.000 description 47
- 239000003921 oil Substances 0.000 description 42
- 235000019198 oils Nutrition 0.000 description 42
- 229910021529 ammonia Inorganic materials 0.000 description 39
- 239000000725 suspension Substances 0.000 description 38
- 239000007787 solid Substances 0.000 description 35
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical compound CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 34
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 32
- 235000011114 ammonium hydroxide Nutrition 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 32
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 21
- 239000000843 powder Substances 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 20
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 17
- 229910052938 sodium sulfate Inorganic materials 0.000 description 16
- 235000011152 sodium sulphate Nutrition 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 11
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 11
- 0 CC(*)(*)C(*)*(C*)=S(C1)(C(*)(*)C(*)=N[C@]1(*)c1cc(BrC)ccc1*)=O Chemical compound CC(*)(*)C(*)*(C*)=S(C1)(C(*)(*)C(*)=N[C@]1(*)c1cc(BrC)ccc1*)=O 0.000 description 10
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 108010064397 amyloid beta-protein (1-40) Proteins 0.000 description 9
- 239000012267 brine Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000007903 gelatin capsule Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 9
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000010 aprotic solvent Substances 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 230000003197 catalytic effect Effects 0.000 description 7
- 238000005191 phase separation Methods 0.000 description 7
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- YWWDBCBWQNCYNR-UHFFFAOYSA-N trimethylphosphine Chemical compound CP(C)C YWWDBCBWQNCYNR-UHFFFAOYSA-N 0.000 description 6
- VTHGSCVSLASTMX-OZAOTIOVSA-N CC(C)(C(NC(OC(C)(C)N1)=O)=N[C@@](C)([C@@H]2CCN=3)c4cc1ccc4F)[S@]2=3=O Chemical compound CC(C)(C(NC(OC(C)(C)N1)=O)=N[C@@](C)([C@@H]2CCN=3)c4cc1ccc4F)[S@]2=3=O VTHGSCVSLASTMX-OZAOTIOVSA-N 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000007170 pathology Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- OSCAXCDVRDNCEG-UHFFFAOYSA-N 5-cyano-3-methylpyridine-2-carboxamide Chemical compound CC1=CC(C#N)=CN=C1C(N)=O OSCAXCDVRDNCEG-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 4
- 235000010378 sodium ascorbate Nutrition 0.000 description 4
- 229960005055 sodium ascorbate Drugs 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JRHPOFJADXHYBR-HTQZYQBOSA-N (1r,2r)-1-n,2-n-dimethylcyclohexane-1,2-diamine Chemical compound CN[C@@H]1CCCC[C@H]1NC JRHPOFJADXHYBR-HTQZYQBOSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- RTSBEPIQHLPRCX-UHFFFAOYSA-N 3,5-dichloropyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=NC=C(Cl)C=C1Cl RTSBEPIQHLPRCX-UHFFFAOYSA-N 0.000 description 3
- YYCZGABKNKALMW-UHFFFAOYSA-N 3,5-difluoropyridine-2-carbonyl chloride Chemical compound FC1=CN=C(C(Cl)=O)C(F)=C1 YYCZGABKNKALMW-UHFFFAOYSA-N 0.000 description 3
- JCRKDZXYYCHBEP-UHFFFAOYSA-N 3,5-dimethylpyridine-2-carbonyl chloride Chemical compound CC1=CN=C(C(Cl)=O)C(C)=C1 JCRKDZXYYCHBEP-UHFFFAOYSA-N 0.000 description 3
- FGQHLHAEBIAFPP-UHFFFAOYSA-N 5-methylpyridine-2-carbonyl chloride Chemical compound CC1=CC=C(C(Cl)=O)N=C1 FGQHLHAEBIAFPP-UHFFFAOYSA-N 0.000 description 3
- 101710150192 Beta-secretase 1 Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000025688 early-onset autosomal dominant Alzheimer disease Diseases 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000015756 familial Alzheimer disease Diseases 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- PSAYJRPASWETSH-UHFFFAOYSA-N pyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CC=N1 PSAYJRPASWETSH-UHFFFAOYSA-N 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- WOADMISSFZLHGL-YBYKNVHQSA-N (ne)-n-[1-(5-bromo-2-fluorophenyl)ethylidene]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)\N=C(/C)C1=CC(Br)=CC=C1F WOADMISSFZLHGL-YBYKNVHQSA-N 0.000 description 2
- JRHPOFJADXHYBR-UHFFFAOYSA-N 1-n,2-n-dimethylcyclohexane-1,2-diamine Chemical compound CNC1CCCCC1NC JRHPOFJADXHYBR-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- SJXXCBFOCXPKSN-UHFFFAOYSA-N 2-chloro-4-cyanobenzamide Chemical compound NC(=O)C1=CC=C(C#N)C=C1Cl SJXXCBFOCXPKSN-UHFFFAOYSA-N 0.000 description 2
- DOPKWYOKCOMXLV-UHFFFAOYSA-N 2-chloro-4-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(C#N)C=C1Cl DOPKWYOKCOMXLV-UHFFFAOYSA-N 0.000 description 2
- BCTCSDKMQQXRKZ-UHFFFAOYSA-N 2-methyl-2-methylsulfanylpropanenitrile Chemical compound CSC(C)(C)C#N BCTCSDKMQQXRKZ-UHFFFAOYSA-N 0.000 description 2
- YZZXHIULTSZKHA-UHFFFAOYSA-N 2-methyl-2-methylsulfinylpropanenitrile Chemical compound CS(=O)C(C)(C)C#N YZZXHIULTSZKHA-UHFFFAOYSA-N 0.000 description 2
- QZASYKCFXACXJX-UHFFFAOYSA-N 2-methylpyrimidine-5-carbonyl chloride Chemical compound CC1=NC=C(C(Cl)=O)C=N1 QZASYKCFXACXJX-UHFFFAOYSA-N 0.000 description 2
- GMDRUGZBWUTQMX-UHFFFAOYSA-N 2-methylpyrimidine-5-carboxamide Chemical compound CC1=NC=C(C(N)=O)C=N1 GMDRUGZBWUTQMX-UHFFFAOYSA-N 0.000 description 2
- ZRIGDBVSVFSVLL-UHFFFAOYSA-N 2-methylsulfanylacetonitrile Chemical compound CSCC#N ZRIGDBVSVFSVLL-UHFFFAOYSA-N 0.000 description 2
- GJHFDLLITMRTDJ-UHFFFAOYSA-N 4-chloro-1-(difluoromethyl)pyrazole-3-carboxamide Chemical compound NC(=O)C1=NN(C(F)F)C=C1Cl GJHFDLLITMRTDJ-UHFFFAOYSA-N 0.000 description 2
- CEBPBELRNHBPSH-UHFFFAOYSA-N 4-cyano-2-methylbenzamide Chemical compound CC1=CC(C#N)=CC=C1C(N)=O CEBPBELRNHBPSH-UHFFFAOYSA-N 0.000 description 2
- OAHQLQVIVUGQOG-UHFFFAOYSA-N 4-cyano-2-methylbenzoyl chloride Chemical compound CC1=CC(C#N)=CC=C1C(Cl)=O OAHQLQVIVUGQOG-UHFFFAOYSA-N 0.000 description 2
- OTCBNPOZZIYFME-UHFFFAOYSA-N 5-(difluoromethoxy)-3-methylpyridine-2-carboxamide Chemical compound CC1=CC(OC(F)F)=CN=C1C(N)=O OTCBNPOZZIYFME-UHFFFAOYSA-N 0.000 description 2
- MXRPGTWXBAALNA-UHFFFAOYSA-N 5-(difluoromethoxy)pyrazine-2-carboxamide Chemical compound NC(=O)C1=CN=C(OC(F)F)C=N1 MXRPGTWXBAALNA-UHFFFAOYSA-N 0.000 description 2
- RNTPJZKCVMCDQV-UHFFFAOYSA-N 5-(difluoromethoxy)pyridine-2-carbonyl chloride Chemical compound FC(OC=1C=CC(=NC=1)C(=O)Cl)F RNTPJZKCVMCDQV-UHFFFAOYSA-N 0.000 description 2
- JRIASDXJZYOBCA-UHFFFAOYSA-N 5-chloropyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=N1 JRIASDXJZYOBCA-UHFFFAOYSA-N 0.000 description 2
- FEAYPWNJNRCLEE-UHFFFAOYSA-N 5-cyano-3-methylpyridine-2-carbonyl chloride Chemical compound CC1=CC(C#N)=CN=C1C(Cl)=O FEAYPWNJNRCLEE-UHFFFAOYSA-N 0.000 description 2
- PFENLEKZZJZJBJ-UHFFFAOYSA-N 5-cyano-3-methylpyridine-2-carboxylic acid Chemical compound CC1=CC(C#N)=CN=C1C(O)=O PFENLEKZZJZJBJ-UHFFFAOYSA-N 0.000 description 2
- UOXBCIPHBHWKFF-UHFFFAOYSA-N 5-cyanopyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=C(C#N)C=N1 UOXBCIPHBHWKFF-UHFFFAOYSA-N 0.000 description 2
- JZAJCSOXMLFIBA-UHFFFAOYSA-N 5-ethoxypyrazine-2-carbonyl chloride Chemical compound CCOC1=CN=C(C(Cl)=O)C=N1 JZAJCSOXMLFIBA-UHFFFAOYSA-N 0.000 description 2
- RDKGMGKRFWFHAF-UHFFFAOYSA-N 5-ethoxypyridine-2-carbonyl chloride Chemical compound C(C)OC=1C=CC(=NC=1)C(=O)Cl RDKGMGKRFWFHAF-UHFFFAOYSA-N 0.000 description 2
- VWBALQQBGOBPHU-UHFFFAOYSA-N 5-ethoxypyridine-2-carboxamide Chemical compound CCOC1=CC=C(C(N)=O)N=C1 VWBALQQBGOBPHU-UHFFFAOYSA-N 0.000 description 2
- IFBZBMDHYAUEJV-UHFFFAOYSA-N 5-fluoropyridine-2-carbonyl chloride Chemical compound FC1=CC=C(C(Cl)=O)N=C1 IFBZBMDHYAUEJV-UHFFFAOYSA-N 0.000 description 2
- LRESNQMTFRFPTL-UHFFFAOYSA-N 5-methoxy-3-methylpyridine-2-carboxamide Chemical compound COc1cnc(C(N)=O)c(C)c1 LRESNQMTFRFPTL-UHFFFAOYSA-N 0.000 description 2
- BLHOBSPLRQJLMC-UHFFFAOYSA-N 5-methoxypyridine-2-carbonyl chloride Chemical compound COC1=CC=C(C(Cl)=O)N=C1 BLHOBSPLRQJLMC-UHFFFAOYSA-N 0.000 description 2
- VFNBCOKXIDBFOC-UHFFFAOYSA-N 5-methylpyridine-2-carboxamide Chemical compound CC1=CC=C(C(N)=O)N=C1 VFNBCOKXIDBFOC-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 201000010374 Down Syndrome Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000002879 Lewis base Substances 0.000 description 2
- 102100040243 Microtubule-associated protein tau Human genes 0.000 description 2
- 101710115937 Microtubule-associated protein tau Proteins 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010050254 Presenilins Proteins 0.000 description 2
- 102000015499 Presenilins Human genes 0.000 description 2
- 206010044688 Trisomy 21 Diseases 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007527 lewis bases Chemical class 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 125000003431 oxalo group Chemical group 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 2
- 229910000105 potassium hydride Inorganic materials 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 239000003586 protic polar solvent Substances 0.000 description 2
- TXJKATOSKLUITR-UHFFFAOYSA-N pyrazine-2-carbonyl chloride Chemical compound ClC(=O)C1=CN=CC=N1 TXJKATOSKLUITR-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- VUPQHSHTKBZVML-UHFFFAOYSA-J rhodium(3+);tetraacetate Chemical compound [Rh+3].[Rh+3].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O VUPQHSHTKBZVML-UHFFFAOYSA-J 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GQIRIWDEZSKOCN-UHFFFAOYSA-N 1-chloro-n,n,2-trimethylprop-1-en-1-amine Chemical compound CN(C)C(Cl)=C(C)C GQIRIWDEZSKOCN-UHFFFAOYSA-N 0.000 description 1
- 125000005955 1H-indazolyl group Chemical group 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- GCUOLJOTJRUDIZ-UHFFFAOYSA-N 2-(2-bromoethoxy)oxane Chemical compound BrCCOC1CCCCO1 GCUOLJOTJRUDIZ-UHFFFAOYSA-N 0.000 description 1
- PSPZPMWNUUAKKA-NPMXOYFQSA-N 2-[[(1R,3R)-5-amino-3-(5-bromo-2-fluorophenyl)-3,6,6-trimethyl-1-oxo-2H-1,4-thiazin-1-ylidene]amino]ethanol Chemical compound CC1(C)C(N)=N[C@@](C)(C[S@]1(=O)=NCCO)C1=C(F)C=CC(Br)=C1 PSPZPMWNUUAKKA-NPMXOYFQSA-N 0.000 description 1
- PSPZPMWNUUAKKA-WNSKOXEYSA-N 2-[[(1S,3R)-5-amino-3-(5-bromo-2-fluorophenyl)-3,6,6-trimethyl-1-oxo-2H-1,4-thiazin-1-ylidene]amino]ethanol Chemical compound CC1(C)C(N)=N[C@@](C)(C[S@@]1(=O)=NCCO)C1=C(F)C=CC(Br)=C1 PSPZPMWNUUAKKA-WNSKOXEYSA-N 0.000 description 1
- VTROYYKGGOPEPS-UHFFFAOYSA-N 2-chloro-4-cyanobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1Cl VTROYYKGGOPEPS-UHFFFAOYSA-N 0.000 description 1
- ACFXCUTUMGEGRR-UHFFFAOYSA-N 2-ethyl-4-methylbenzenesulfonic acid Chemical compound CCC1=CC(C)=CC=C1S(O)(=O)=O ACFXCUTUMGEGRR-UHFFFAOYSA-N 0.000 description 1
- CESUXLKAADQNTB-SSDOTTSWSA-N 2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@](N)=O CESUXLKAADQNTB-SSDOTTSWSA-N 0.000 description 1
- NMGIXZFBQPETOK-UHFFFAOYSA-N 2-methylpyrimidine-5-carboxylic acid Chemical compound CC1=NC=C(C(O)=O)C=N1 NMGIXZFBQPETOK-UHFFFAOYSA-N 0.000 description 1
- UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical compound C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 description 1
- 125000004011 3 membered carbocyclic group Chemical group 0.000 description 1
- JYKZCYLZWZCQFP-UHFFFAOYSA-N 3,5-dichloropyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(Cl)C=C1Cl JYKZCYLZWZCQFP-UHFFFAOYSA-N 0.000 description 1
- LWKSZYXOBLMONP-UHFFFAOYSA-N 3,5-difluoropyridine-2-carboxamide Chemical compound NC(=O)C1=NC=C(F)C=C1F LWKSZYXOBLMONP-UHFFFAOYSA-N 0.000 description 1
- QKLXAJQKMIWFRC-UHFFFAOYSA-N 3,5-difluoropyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(F)C=C1F QKLXAJQKMIWFRC-UHFFFAOYSA-N 0.000 description 1
- CRQQOEOERUUJFO-UHFFFAOYSA-N 3,5-dimethylpyridine-2-carboxylic acid Chemical compound CC1=CN=C(C(O)=O)C(C)=C1 CRQQOEOERUUJFO-UHFFFAOYSA-N 0.000 description 1
- RCMYAWBHURQNSA-UHFFFAOYSA-N 3-chloro-5-(difluoromethoxy)pyridine-2-carbonyl chloride Chemical compound ClC=1C(=NC=C(C=1)OC(F)F)C(=O)Cl RCMYAWBHURQNSA-UHFFFAOYSA-N 0.000 description 1
- OBWSTQFVHUFLIY-UHFFFAOYSA-N 3-chloro-5-(difluoromethoxy)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(OC(F)F)C=C1Cl OBWSTQFVHUFLIY-UHFFFAOYSA-N 0.000 description 1
- SNIMEAODTKIPAR-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)pyridine-2-carbonyl chloride Chemical compound FC(F)(F)C1=CN=C(C(Cl)=O)C(Cl)=C1 SNIMEAODTKIPAR-UHFFFAOYSA-N 0.000 description 1
- HXRMCZBDTDCCOP-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(C(F)(F)F)C=C1Cl HXRMCZBDTDCCOP-UHFFFAOYSA-N 0.000 description 1
- PZHXPDWMMWRINA-UHFFFAOYSA-N 3-chloro-5-cyanopyridine-2-carbonyl chloride Chemical compound ClC=1C(=NC=C(C=1)C#N)C(=O)Cl PZHXPDWMMWRINA-UHFFFAOYSA-N 0.000 description 1
- NLRLAFKVKGGETJ-UHFFFAOYSA-N 3-chloro-5-cyanopyridine-2-carboxamide Chemical compound NC(=O)C1=NC=C(C#N)C=C1Cl NLRLAFKVKGGETJ-UHFFFAOYSA-N 0.000 description 1
- NHQRPMDOQOKWPU-UHFFFAOYSA-N 3-chloro-5-cyanopyridine-2-carboxylic acid Chemical compound OC(=O)C1=NC=C(C#N)C=C1Cl NHQRPMDOQOKWPU-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HUBOTQVVYJUKOV-UHFFFAOYSA-N 3-methylpyridine-2-carbonyl chloride Chemical compound CC1=CC=CN=C1C(Cl)=O HUBOTQVVYJUKOV-UHFFFAOYSA-N 0.000 description 1
- JHNLZOVBAQWGQU-UHFFFAOYSA-N 380814_sial Chemical compound CS(O)(=O)=O.O=P(=O)OP(=O)=O JHNLZOVBAQWGQU-UHFFFAOYSA-N 0.000 description 1
- 125000001845 4 membered carbocyclic group Chemical group 0.000 description 1
- UZAVRPHVCPZWTH-UHFFFAOYSA-N 4-chloro-1-(difluoromethyl)pyrazole-3-carbonyl chloride Chemical compound ClC=1C(=NN(C=1)C(F)F)C(=O)Cl UZAVRPHVCPZWTH-UHFFFAOYSA-N 0.000 description 1
- CJHLWLUPTLVMPW-UHFFFAOYSA-N 4-chloro-1-(difluoromethyl)pyrazole-3-carboxylic acid Chemical compound OC(=O)C1=NN(C(F)F)C=C1Cl CJHLWLUPTLVMPW-UHFFFAOYSA-N 0.000 description 1
- NIDKGLRXRBFGEN-UHFFFAOYSA-N 4-cyano-2-methylbenzoic acid Chemical compound CC1=CC(C#N)=CC=C1C(O)=O NIDKGLRXRBFGEN-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- QWKKYJLAUWFPDB-UHFFFAOYSA-N 4-nitrobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 QWKKYJLAUWFPDB-UHFFFAOYSA-N 0.000 description 1
- QMABMHJGSFUTPF-UHFFFAOYSA-N 4-tert-butyl-2,6-bis(4-tert-butylpyridin-2-yl)pyridine Chemical compound CC(C)(C)C1=CC=NC(C=2N=C(C=C(C=2)C(C)(C)C)C=2N=CC=C(C=2)C(C)(C)C)=C1 QMABMHJGSFUTPF-UHFFFAOYSA-N 0.000 description 1
- 125000001054 5 membered carbocyclic group Chemical group 0.000 description 1
- RZPUVLBTEKZASJ-UHFFFAOYSA-N 5-(2,2,3,3-tetrafluoropropoxy)pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=C(OCC(F)(F)C(F)F)C=N1 RZPUVLBTEKZASJ-UHFFFAOYSA-N 0.000 description 1
- ZKSRBXYNQVEQQZ-UHFFFAOYSA-N 5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carbonyl chloride Chemical compound FC(COC=1C=CC(=NC=1)C(=O)Cl)(C(F)F)F ZKSRBXYNQVEQQZ-UHFFFAOYSA-N 0.000 description 1
- DBADNJPSKGVYJM-UHFFFAOYSA-N 5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(OCC(F)(F)C(F)F)C=N1 DBADNJPSKGVYJM-UHFFFAOYSA-N 0.000 description 1
- YMPDXOSWMXOXAF-UHFFFAOYSA-N 5-(2,2-difluoroethoxy)pyrazine-2-carbonyl chloride Chemical compound FC(COC=1N=CC(=NC=1)C(=O)Cl)F YMPDXOSWMXOXAF-UHFFFAOYSA-N 0.000 description 1
- PBJZKVWVDFJTRA-UHFFFAOYSA-N 5-(2,2-difluoroethoxy)pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=C(OCC(F)F)C=N1 PBJZKVWVDFJTRA-UHFFFAOYSA-N 0.000 description 1
- PRZMYXQBLQGWGN-UHFFFAOYSA-N 5-(2,2-difluoroethoxy)pyridine-2-carbonyl chloride Chemical compound FC(COC=1C=CC(=NC=1)C(=O)Cl)F PRZMYXQBLQGWGN-UHFFFAOYSA-N 0.000 description 1
- IQPVMOFLYFFTLR-UHFFFAOYSA-N 5-(2,2-difluoroethoxy)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(OCC(F)F)C=N1 IQPVMOFLYFFTLR-UHFFFAOYSA-N 0.000 description 1
- MPUCCONMRYCLOV-UHFFFAOYSA-N 5-(difluoromethoxy)-3-methylpyridine-2-carbonyl chloride Chemical compound FC(OC=1C=C(C(=NC=1)C(=O)Cl)C)F MPUCCONMRYCLOV-UHFFFAOYSA-N 0.000 description 1
- BJSGKNMBNWQGOX-UHFFFAOYSA-N 5-(difluoromethoxy)-3-methylpyridine-2-carboxylic acid Chemical compound CC1=CC(OC(F)F)=CN=C1C(O)=O BJSGKNMBNWQGOX-UHFFFAOYSA-N 0.000 description 1
- SDABZVXAEJIMIN-UHFFFAOYSA-N 5-(difluoromethoxy)pyrazine-2-carbonyl chloride Chemical compound FC(OC=1N=CC(=NC=1)C(=O)Cl)F SDABZVXAEJIMIN-UHFFFAOYSA-N 0.000 description 1
- ZOPAAVWYROLCAA-UHFFFAOYSA-N 5-(difluoromethoxy)pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=C(OC(F)F)C=N1 ZOPAAVWYROLCAA-UHFFFAOYSA-N 0.000 description 1
- QOGGIPBAUKZCGU-UHFFFAOYSA-N 5-(difluoromethoxy)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(OC(F)F)C=N1 QOGGIPBAUKZCGU-UHFFFAOYSA-N 0.000 description 1
- ZBPYOEMMLMVVQT-UHFFFAOYSA-N 5-chloropyridine-2-carboxamide Chemical compound NC(=O)C1=CC=C(Cl)C=N1 ZBPYOEMMLMVVQT-UHFFFAOYSA-N 0.000 description 1
- GJLOKYIYZIOIPN-UHFFFAOYSA-N 5-chloropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)C=N1 GJLOKYIYZIOIPN-UHFFFAOYSA-N 0.000 description 1
- HRLVPHGCEGTVLK-UHFFFAOYSA-N 5-cyanopyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(C#N)C=N1 HRLVPHGCEGTVLK-UHFFFAOYSA-N 0.000 description 1
- LQMBFTKKBNTWEF-UHFFFAOYSA-N 5-ethoxypyrazine-2-carboxylic acid Chemical compound CCOC1=CN=C(C(O)=O)C=N1 LQMBFTKKBNTWEF-UHFFFAOYSA-N 0.000 description 1
- MIAFDYLZQGBCMZ-UHFFFAOYSA-N 5-ethoxypyridine-2-carboxylic acid Chemical compound CCOC1=CC=C(C(O)=O)N=C1 MIAFDYLZQGBCMZ-UHFFFAOYSA-N 0.000 description 1
- JTKFIIQGMVKDNZ-UHFFFAOYSA-N 5-fluoropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(F)C=N1 JTKFIIQGMVKDNZ-UHFFFAOYSA-N 0.000 description 1
- UHQDYSSLXTZISQ-UHFFFAOYSA-N 5-methoxy-3-methylpyridine-2-carbonyl chloride Chemical compound COC=1C=C(C(=NC=1)C(=O)Cl)C UHQDYSSLXTZISQ-UHFFFAOYSA-N 0.000 description 1
- DBNKNBWKNLLPLN-UHFFFAOYSA-N 5-methoxy-3-methylpyridine-2-carboxylic acid Chemical compound COC1=CN=C(C(O)=O)C(C)=C1 DBNKNBWKNLLPLN-UHFFFAOYSA-N 0.000 description 1
- YPKUGKJFOOZLHN-UHFFFAOYSA-N 5-methoxypyridine-2-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)N=C1 YPKUGKJFOOZLHN-UHFFFAOYSA-N 0.000 description 1
- HWMYXZFRJDEBKC-UHFFFAOYSA-N 5-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)N=C1 HWMYXZFRJDEBKC-UHFFFAOYSA-N 0.000 description 1
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 1
- 125000003627 8 membered carbocyclic group Chemical group 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 102000014303 Amyloid beta-Protein Precursor Human genes 0.000 description 1
- 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 description 1
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 101150058765 BACE1 gene Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- JDVLGUAWWGTTMG-UHFFFAOYSA-N C1=CC=CC=C1.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O Chemical compound C1=CC=CC=C1.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O JDVLGUAWWGTTMG-UHFFFAOYSA-N 0.000 description 1
- GFTZOVWMBHUJPG-INZNITTPSA-N CC(C)(C(N)=N[C@@](C)(C1CCN=2)c3cc(NC(c4c(C)cc(C)cn4)=O)ccc3F)[S@]1=2=O Chemical compound CC(C)(C(N)=N[C@@](C)(C1CCN=2)c3cc(NC(c4c(C)cc(C)cn4)=O)ccc3F)[S@]1=2=O GFTZOVWMBHUJPG-INZNITTPSA-N 0.000 description 1
- TVORWXLXWSTRPQ-KSLFGHPJSA-N CC(C)(C(N)=N[C@@](C)(C1CCN=2)c3cc(NC(c4cnc(C)nc4)=O)ccc3F)[S@]1=2=O Chemical compound CC(C)(C(N)=N[C@@](C)(C1CCN=2)c3cc(NC(c4cnc(C)nc4)=O)ccc3F)[S@]1=2=O TVORWXLXWSTRPQ-KSLFGHPJSA-N 0.000 description 1
- FFWZIDJYTKTCMJ-INCWNZBPSA-N CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)c(C)cc4OC)=O)ccc3F)[S@]1=2=O Chemical compound CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)c(C)cc4OC)=O)ccc3F)[S@]1=2=O FFWZIDJYTKTCMJ-INCWNZBPSA-N 0.000 description 1
- WNYXVVHEPSBAEH-WVSGJHDHSA-N CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)ccc4Cl)=O)ccc3F)[S@]1=2=O Chemical compound CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)ccc4Cl)=O)ccc3F)[S@]1=2=O WNYXVVHEPSBAEH-WVSGJHDHSA-N 0.000 description 1
- VFAVDRKPGHTWKT-BFQPASHQSA-N CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)cnc4OCC(F)F)=O)ccc3F)[S@]1=2=O Chemical compound CC(C)(C(N)=N[C@@](C)([C@@H]1CCN=2)c3cc(NC(c(nc4)cnc4OCC(F)F)=O)ccc3F)[S@]1=2=O VFAVDRKPGHTWKT-BFQPASHQSA-N 0.000 description 1
- ZYHHCTMKCFCYOH-RPWUZVMVSA-N CC(C)(C(N)=N[C@]1(C)c2cc(NC(c(nc3)ccc3OCC(F)F)=O)ccc2F)S[C@]1(CCN)NC Chemical compound CC(C)(C(N)=N[C@]1(C)c2cc(NC(c(nc3)ccc3OCC(F)F)=O)ccc2F)S[C@]1(CCN)NC ZYHHCTMKCFCYOH-RPWUZVMVSA-N 0.000 description 1
- OOCYGPINVMVSOD-SXOMAYOGSA-N CC(C)(C)OC(NC(C(C)(C)S[C@]1(CCN)NC)=N[C@]1(C)c1cc(NC(c(nc2)ccc2Cl)=O)ccc1F)=O Chemical compound CC(C)(C)OC(NC(C(C)(C)S[C@]1(CCN)NC)=N[C@]1(C)c1cc(NC(c(nc2)ccc2Cl)=O)ccc1F)=O OOCYGPINVMVSOD-SXOMAYOGSA-N 0.000 description 1
- UHYODTAHLWTAGM-LQUBDEEZSA-N CC(C)(C)OC(NC(C(C)(C)[S@@]1=CN[C@@]11CCN)=N[C@]1(C)c1cc(NC(c(nc2)ccc2OCC(F)F)=O)ccc1F)=O Chemical compound CC(C)(C)OC(NC(C(C)(C)[S@@]1=CN[C@@]11CCN)=N[C@]1(C)c1cc(NC(c(nc2)ccc2OCC(F)F)=O)ccc1F)=O UHYODTAHLWTAGM-LQUBDEEZSA-N 0.000 description 1
- AXKLJFAORHYJFC-DNOKHDCISA-N CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c(nc2)c(C)cc2OC(F)F)=O)ccc1F)=O Chemical compound CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c(nc2)c(C)cc2OC(F)F)=O)ccc1F)=O AXKLJFAORHYJFC-DNOKHDCISA-N 0.000 description 1
- FLQOVZACLSTKHT-PZHABIFZSA-N CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c(nc2)c(C)cc2OC)=O)ccc1F)=O Chemical compound CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c(nc2)c(C)cc2OC)=O)ccc1F)=O FLQOVZACLSTKHT-PZHABIFZSA-N 0.000 description 1
- AJABEIPOVBJKTG-WADHJSKCSA-N CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c2c(C)cc(C)cn2)=O)ccc1F)=O Chemical compound CC(C)(C)OC(NC(C(C)(C)[S@]1(=NCC[C@H]11)=O)=N[C@]1(C)c1cc(NC(c2c(C)cc(C)cn2)=O)ccc1F)=O AJABEIPOVBJKTG-WADHJSKCSA-N 0.000 description 1
- PMYBVVGKUDUCLP-IKDMDFKBSA-N CC1(C)[S@@]2=CN[C@]2(CCN)[C@@](C)(c2cc(NC(C)(C)O3)ccc2F)N=C1NC3=O Chemical compound CC1(C)[S@@]2=CN[C@]2(CCN)[C@@](C)(c2cc(NC(C)(C)O3)ccc2F)N=C1NC3=O PMYBVVGKUDUCLP-IKDMDFKBSA-N 0.000 description 1
- 101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 101100268553 Homo sapiens APP gene Proteins 0.000 description 1
- 101000617536 Homo sapiens Presenilin-1 Proteins 0.000 description 1
- 101000679365 Homo sapiens Putative tyrosine-protein phosphatase TPTE Proteins 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 1
- 101100348848 Mus musculus Notch4 gene Proteins 0.000 description 1
- 101100317378 Mus musculus Wnt3 gene Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000014736 Notch Human genes 0.000 description 1
- 108010070047 Notch Receptors Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 101100352419 Pithecopus hypochondrialis psn1 gene Proteins 0.000 description 1
- 101100352425 Pithecopus hypochondrialis psn2 gene Proteins 0.000 description 1
- 102100022033 Presenilin-1 Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102100022578 Putative tyrosine-protein phosphatase TPTE Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101000767160 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Intracellular protein transport protein USO1 Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000003016 alphascreen Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000007792 alzheimer disease pathology Effects 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
- 230000003941 amyloidogenesis Effects 0.000 description 1
- ODTWJXLEAFNUPT-UHFFFAOYSA-N aniline;azide Chemical compound [N-]=[N+]=[N-].NC1=CC=CC=C1 ODTWJXLEAFNUPT-UHFFFAOYSA-N 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- XGIUDIMNNMKGDE-UHFFFAOYSA-N bis(trimethylsilyl)azanide Chemical compound C[Si](C)(C)[N-][Si](C)(C)C XGIUDIMNNMKGDE-UHFFFAOYSA-N 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000004970 emotional disturbance Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 238000013230 female C57BL/6J mice Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- CTRLRINCMYICJO-UHFFFAOYSA-N phenyl azide Chemical compound [N-]=[N+]=NC1=CC=CC=C1 CTRLRINCMYICJO-UHFFFAOYSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000005412 pyrazyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- 229960002324 trifluoperazine Drugs 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15180767 | 2015-08-12 | ||
| EP15180767.4 | 2015-08-12 | ||
| PCT/EP2016/068830 WO2017025491A1 (en) | 2015-08-12 | 2016-08-08 | Bace1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018522915A JP2018522915A (ja) | 2018-08-16 |
| JP2018522915A5 JP2018522915A5 (enExample) | 2019-09-12 |
| JP6895424B2 true JP6895424B2 (ja) | 2021-06-30 |
Family
ID=53835951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018506862A Expired - Fee Related JP6895424B2 (ja) | 2015-08-12 | 2016-08-08 | Ｂａｃｅ１阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10246468B2 (enExample) |
| EP (1) | EP3334742B1 (enExample) |
| JP (1) | JP6895424B2 (enExample) |
| CN (1) | CN107683283B (enExample) |
| WO (1) | WO2017025491A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6895424B2 (ja) * | 2015-08-12 | 2021-06-30 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂａｃｅ１阻害剤 |
| PT3848054T (pt) | 2018-09-06 | 2025-04-03 | Daiichi Sankyo Co Ltd | Conjugados anticorpo-fármaco de derivados de dinucleótidos cíclicos |
| CA3135276A1 (en) | 2019-04-17 | 2020-10-22 | Bard Access Systems, Inc. | Catheter securement device including extended anchor pad and release liner clasping features |
| CN116059192B (zh) | 2019-11-13 | 2024-10-29 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸及其衍生物的用途 |
| WO2024169952A1 (en) | 2023-02-16 | 2024-08-22 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103874496A (zh) * | 2011-08-22 | 2014-06-18 | 默沙东公司 | 作为bace抑制剂的2-螺-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其用途 |
| US9540392B2 (en) * | 2012-05-21 | 2017-01-10 | Bayer Pharma Aktiengesellschaft | Thienopyrimidines |
| UA113438C2 (xx) * | 2012-05-24 | 2017-01-25 | 5-аміно$1,4]тіазини як інгібітори бета-секретази 1 | |
| MX2015008957A (es) * | 2013-01-22 | 2015-09-29 | Siena Biotech Spa | Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1). |
| EP2968357B1 (en) * | 2013-03-15 | 2018-07-04 | Merck Sharp & Dohme Corp. | S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use |
| RU2016128365A (ru) * | 2013-12-20 | 2018-01-25 | Ф. Хоффманн-Ля Рош Аг | 5-арил-1-имино-1-оксо-[1,2,4]тиадиазины |
| CN106661053B (zh) * | 2014-07-25 | 2019-07-12 | 豪夫迈·罗氏有限公司 | 吡啶基-三氮杂二环类化合物 |
| JP6568937B2 (ja) * | 2014-10-10 | 2019-08-28 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂａｃｅ１阻害剤 |
| US9920072B2 (en) * | 2014-11-03 | 2018-03-20 | Hoffmann-La Roche Inc. | BACE1 inhibitors |
| JP6895424B2 (ja) * | 2015-08-12 | 2021-06-30 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂａｃｅ１阻害剤 |
-
2016
- 2016-08-08 JP JP2018506862A patent/JP6895424B2/ja not_active Expired - Fee Related
- 2016-08-08 WO PCT/EP2016/068830 patent/WO2017025491A1/en not_active Ceased
- 2016-08-08 EP EP16754452.7A patent/EP3334742B1/en not_active Not-in-force
- 2016-08-08 CN CN201680031828.0A patent/CN107683283B/zh not_active Expired - Fee Related
- 2016-08-08 US US15/735,890 patent/US10246468B2/en not_active Expired - Fee Related
-
2019
- 2019-02-13 US US16/274,911 patent/US10696691B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20190002476A1 (en) | 2019-01-03 |
| JP2018522915A (ja) | 2018-08-16 |
| WO2017025491A1 (en) | 2017-02-16 |
| US20190270757A1 (en) | 2019-09-05 |
| CN107683283A (zh) | 2018-02-09 |
| EP3334742A1 (en) | 2018-06-20 |
| EP3334742B1 (en) | 2019-05-08 |
| US10696691B2 (en) | 2020-06-30 |
| US10246468B2 (en) | 2019-04-02 |
| CN107683283B (zh) | 2021-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10696691B2 (en) | BACE1 inhibitors | |
| CN104470915B (zh) | 作为bace1抑制剂的二氟-六氢-环戊二烯并噁嗪基类和二氟-六氢-苯并噁嗪基类 | |
| CN103827110A (zh) | 作为BACE1抑制剂的N-(3-(2-氨基-6,6-二氟-4,4a,5,6,7,7a-六氢-环戊二烯并[e][1,3]噁嗪-4-基)-苯基)-酰胺 | |
| EA032662B1 (ru) | ПРОИЗВОДНЫЕ 4-АМИНО-6-ФЕНИЛ-5,6-ДИГИДРОИМИДАЗО[1,5-а]ПИРАЗИН-3(2H)-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE) | |
| US10829500B2 (en) | Pyridyl-triazabicycles | |
| JP6554547B2 (ja) | Ｂａｃｅ１阻害剤 | |
| RU2712272C2 (ru) | Ингибиторы бета-секретазы | |
| US9540397B2 (en) | BACE1 inhibitors | |
| JP6543697B2 (ja) | ２，２，２−トリフルオロエチル−チアジアジン類 | |
| HK1233249B (zh) | Bace1抑制剂 | |
| HK1249516A1 (en) | Bace1 inhibitors | |
| HK1233249A1 (en) | Bace1 inhibitors | |
| TW201317233A (zh) | 作為ＢＡＣＥ１抑制劑之Ｎ－（３－（２－胺基－６，６－二氟基－４，４ａ，５，６，７，７ａ－六氫環戊［ｅ］［１，３］□－４－基）苯基）醯胺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190801 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190801 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200611 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200616 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200819 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201214 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210511 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210607 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6895424 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |